Pandipedia entry
Past ClinicalTrials.gov quality signals, not current performance
This is a retrospective look at registry quality signals in ClinicalTrials.gov, not a report of current performance.
The registry-record analysis examined 79,413 ClinicalTrials.gov records.
In the planned-analysis sample, 61% of first primary outcome entries were too vague to identify a measurement or domain.
The posted-results review analyzed 2,178 publicly posted results records.
Among posted results records, 20% reported more than two primary outcomes, and sponsors or investigators self-reported the data without an independent verification source.
1/5
Save this answer
Create your account to keep this answer and continue from it later.
Sorry, Pandi could not find an answer.
Let's look at alternatives:
- Modify the query.
- Start a new thread.
- Remove sources (if manually added).
Continue exploring
Explore related topics
ClinicalTrials.gov results: useful evidence or reporting trap?. Synthesize what the results database adds to journal publications, then assess major interpretation risks including self reporting, missing fields, inconsistent entries, imprecise outcome definitions, incomplete participant result reporting, and incomplete registry coverage. Include a compact table separating what reviewers can extract, what they should verify, and what should be treated cautiously.Why does linking survey and administrative data improve income measurement without eliminating bias?. Structure the report around what surveys, tax records, and programme records each capture, followed by linkage rates, inverse-probability weighting, allocation and imputation decisions, and privacy-preserving linkage. Include a section on why the Gini coefficient can conceal where inequality is concentrated, and distinguish prototype or exploratory findings from established general conclusions.What did SEC oversight records say about the TCR program?. Structure the report around four sections: the OIG finding that the TCR program could be further strengthened, the planned analytics and automation system, audit planning activity, and known limits in report generation functionality. Include a source table with dates and a caveats section noting where the excerpts do not establish outcomes after the planned modernization.The Stevenson Family's Engineering Legacy: From Thomas Smith to Robert StevensonFive findings from Uttar Pradesh’s district earnings mapA high match rate can still misleadWhy SDG health indicators are harder to measure than they lookComparing semaglutide and tirzepatide for weight loss. Synthesize the comparative evidence in sections covering study designs, populations, total body weight loss outcomes, safety and tolerability, heterogeneity, and head-to-head limitations. Include a compact table distinguishing what is strongly supported from what remains uncertain.